3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Laryngeal Diseases
1
Head and Neck Neoplasms
1
Interventions
Specimen Handling
71
Magnetic Resonance Spectroscopy
55
Biopsy
43
pembrolizumab
25
Carboplatin
25
Radiation
24
Radiotherapy
23
Cyclophosphamide
23
Nivolumab
21
Paclitaxel
20
Cisplatin
20
olaparib
18
Etoposide
18
Doxorubicin
17
X-Rays
16
Vincristine
16
Taxes
15
Immunoglobulin G
15
Disulfides
15
Radiotherapy, Intensity-Modulated
14
Leucovorin
14
Dexamethasone
14
Cytarabine
14
Bevacizumab
14
durvalumab
13
Prednisone
13
Platinum
13
1,2-diaminocyclohexaneplatinum II citrate
13
Methotrexate
11
Ipilimumab
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
monalizumab
×
30 days
×
Clear all
NCT04590963
2026-06-01
INTERLINK-1
AstraZeneca
Phase 3
Active not recruiting
370 enrolled
21 charts